Scientists have developed a treatment for pulmonary fibrosis by using nanoparticles coated in mannose -- a type of sugar -- to stop a population of lung cells called macrophages that contribute to lung tissue scarring. The cell-targeting method holds promise for preventing this severe lung scarring disease, which can result in life-threatening complications like shortness of breath.
